Published in:
01-08-2019 | Antibiotic | Brief Report
Ceftaroline as salvage therapy for complicated MRSA bacteremia: case series and analysis
Published in: Infection | Issue 4/2019
Login to get accessAbstract
Introduction
Methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infection (BSI) is a major cause of morbidity and mortality in hospitalized patients. Ceftaroline fosamil (CPT) is the only available beta-lactam antibiotic with in vitro and in vivo activities against MRSA. There is currently limited clinical experience with CPT in complicated MRSA BSI.
Materials and Methods
We report a series of eight patients, including three whose strains had reduced susceptibility to vancomycin.
Results
CPT monotherapy was successfully used as salvage therapy for complicated MRSA BSI. The median time to documented clearance was 7 days.
Conclusion
Ceftaroline monotherapy is effective for clearance of refractory MRSA BSI related to implanted devices, endocarditis, and orthopedic infections.